Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients.

Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients.

OBJECTIVE:The aim of this study was to investigate if the treatment outcomes of checkpoint inhibitors (CPI) in patients with advanced-stage skin head and neck melanoma (HNM) differs from outcomes in patients with non-HNM. DESIGN:A retrospective cohort study of patients with unresectable AJCC stage I...

Full description

Bibliographic Details
Main Authors: Nir Hirshoren, Roni Yoeli, Jonathan E Cohen, Jeffrey M Weinberger, Nadia Kaplan, Sharon Merims, Tamar Peretz, Michal Lotem
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0231038

Internet

https://doi.org/10.1371/journal.pone.0231038

Similar Items